SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-002379
Filing Date
2024-01-26
Accepted
2024-01-26 17:28:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-noticeofinternetav.htm DEFA14A 7741
2 a0001.jpg GRAPHIC 558601
3 a0002.jpg GRAPHIC 419871
4 image_0.jpg GRAPHIC 238
5 image_1.jpg GRAPHIC 237
6 image_17.jpg GRAPHIC 386
7 image_2.jpg GRAPHIC 226
  Complete submission text file 0001628280-24-002379.txt   1357730
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38042 | Film No.: 24569295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)